On March 3, 2020 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, reported that management will present an overview of the company’s business strategy and development-stage programs at the Barclays Global Healthcare Conference 2020 being held in Miami (Press release, Spectrum Pharmaceuticals, MAR 3, 2020, View Source [SID1234555129]). The company presentation is scheduled for Tuesday, March 10, 2020, at 4:50 p.m. EDT.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
A live webcast of the presentation will be available on Spectrum’s website at View Source with a replay available shortly after the event.